Company Profile

Fina Biosolutions LLC
Profile last edited on: 10/13/21      CAGE: 4WZ88      UEI: DV4LJ9BSNXH7

Business Identifier: Affordable protein polysaccharide conjugates for vaccines
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9430 Key West Avenue Suite 200
Rockville, MD 20850
   (877) 346-2246
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

Initially structured around enabling emerging market vaccine manufacturers to learn how to make affordable protein polysaccharide conjugates for vaccines, FinaBio is now a premier provider of conjugate vaccine laboratory and consulting services for the Biotech and Vaccine industry world-wide. Located in the heart of the Maryland biotechnology corridor, the firm offers a well-equipped laboratory for molecular biology and protein expression, conjugation, and conjugate vaccine characterization. Our scientists collaborate with universities such as Johns Hopkins and the University of Maryland, as well as the local biotechnology community to expand their resources.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $289,089
Project Title: Genetically Detoxified Tetanus Toxin for Use in Vaccines
0 1 NIH $297,809
Project Title: E. coli platform for expression of low-cost malaria fusion proteins

Key People / Management

  Andrew Lees -- CEO and Chief Scientific Officer

Company News

There are no news available.